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HOUSTON LAW REVIEW
INTRODUCTION
Kenneth R. Wing*
The problem of providing satisfactory medical service to all
the people of the United States at costs which they can meet is a
pressing one. At the present time, many persons do not receive
service which is adequate either in quantity or quality, and the
costs of service are inequably distributed. The result is a tremen-
dous amount of preventable physical pain and mental anguish,
needless deaths, economic inefficiency, and social waste. Further-
more, these conditions are, as the following pages will show,
largely unnecessary. The United States has the economic re-
sources, the organizing ability, and the technical experience to
solve the problem.'
Surely much has changed since the Committee on the Costs of
Medical Care (CCMC) issued its controversial report in 1933. The
government's role in health care has been vastly reshaped and ex-
panded. Public and private third-party payment programs, essen-
tially nonexistent at the time of the CCMC report, now provide
some form of insurance coverage for nearly ninety percent of the
population. In these regards, the CCMC recommendations proved
to be remarkably prophetic. At the same time, even the most vi-
sionary members of the committee could not have anticipated the
several waves of technological progress in medicine which would
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soon follow; nor would they likely recognize today's array of insti-
tutional and individual providers, from which Americans receive
their health care, as the successors of the simple hospital and the
office-based physician that were the primary models for delivering
medical care in the 1930s. American health care has come a long
way in little more than one generation.
To rephrase Joseph Califano's assessment of our present cir-
cumstances, the more things change, the more they stay the same.2
The most remarkable consequence of the CCMC report is not that
it provides a benchmark by which to judge how long we have strug-
gled to improve health care in this country and to assess how far
we have come; instead, the most remarkable consequence is that it
reminds us that despite all that has transpired the "pressing prob-
lem" has changed so little. Today's report might cast a somewhat
different spin on its assessment of the availability of medical care
to all Americans: access to adequate care is still a problem for
some-too many-Americans, but the incidence of denied access is
far more exceptional today. Similar to all contemporary assess-
ments of health care in this country, today's report would likely
begin with a recounting of the ever increasing levels of economic
resources that we collectively spend on health care, rather than di-
rect its primary focus on the inequitable impact of health care
costs on some individuals, as did the CCMC report. But the es-
sence of today's problem remains the same as it has for the last
fifty years: we still need to find some way to provide an adequate
level of medical care for all Americans at an acceptable cost. This
is the fundamental and immutable dilemma of American health
policy.
Consequently, some people take issue with those assessments
of our current circumstances that focus too heavily on the "cost
problem," particularly those that insist health care spending in
this country is approaching some critical level which, when
reached, will force us to adopt some unprecedented form of re-
source rationing. If the Reagan years have reaffirmed any previ-
ously demonstrated lesson, it must be that our appetite for what
we regard as necessary to our health, or to that of our fellow Amer-
icans, is almost beyond constraint. The Reagan administration suc-
cessfully orchestrated the most significant reductions in domestic
2. Califano, American's Health Care Revolution: Now Comes the Tough Part, 26 Hous.
L. REv. 7, 8. (1989).
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spending priorities since the Depression. Yet virtually every at-
tempt by the administration to restructure Medicaid or Medicare,
in a fashion which visibly threatened the availability of services
funded by those programs, was quickly rebuffed. The central part
of Reagan's conservative health policy strategy, a limitation on the
tax exclusion that indirectly subsidizes employer-purchased health
insurance, was repeatedly rejected by Congress.
Even in the face of annual federal budget deficits exceeding
200 billion dollars per year, Medicaid and Medicare-representing
over 40 percent of the federal domestic budget-were exempted
from the Gramm-Rudman automatic budget controls.3 Indeed, by
the end of his term, President Reagan was signing with feigned
enthusiasm a catastrophic health bill, further extending the federal
commitment to finance health care.'
These are hardly indications of a society engaged in a frontal,
singleminded attack on a "cost problem." Rather, they are indica-
tions of our strong, deeply embedded commitment to health care.
All of us should be, and many of us are, deeply concerned with the
costs of that commitment, as purchasers of insurance, consumers
of services, tax payers, public officials, participants in a not-always-
healthy economy. To state our concern in that way, however, only
highlights the fact that rising health care costs present us not with
a single or focal problem but with a series of related, complex, and
often conflicting problems which are only partially defined by their
price tag. Surely we cannot afford to ignore a health care bill that
will soon exceed 600 billion dollars annually or that has essentially
doubled its share of the gross national product (GNP) in the last
fifteen years.
Before we spend, as is now predicted, 5 twelve percent of our
economic product on health care next year or fifteen percent annu-
ally by the end of the century, it is crucial that we first ask
whether we will be getting value for our dollars, and whether we
will be willing to forego those things which we will be unable to
buy because of the predicted increased spending on health care.
Surely if we are about to purchase services that are inefficiently
provided, or of questionable quality, we could say that twelve per-
3. Medicare Catastrophic Coverage Act of 1988, Pub. L. No. 100-360, 102 Stat. 683
(1988).
4. Id.
5. Health Care Financing Administration, National Health Expenditure 19S6-2000, 8
HEALTH CARE FIN. REV. 1 (1987).
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cent of the GNP will be too much to pay. If we will be paying
disproportionately higher prices for the same levels of services,
surely something must be done before we pay for such inflation. If,
however, we pair the prediction that we will spend twelve percent
of our economic product on health care next year with an an-
nouncement that modern medicine can now provide Americans
with a cure for cancer, or for the elimination of the AIDS virus,
then twelve, or even fifteen percent of the GNP may suddenly
sound like a bargain. In this country, health care policy involves a
constant reassessment of the accessibility, the quality, and the
costs of our health care; and although not entirely contradictory, it
involves the balancing of complicated and conflicting social objec-
tives in light of our resources, our technology, and our past experi-
ence. There is no single problem to focus upon, any more than
there could be a single or permanent resolution.
What then are the health policy issues that are of importance
to the legal community as we approach the 1990s? What follows in
this volume documents the seemingly contradictory observation
that much is new and much has stayed the same for over half a
century. Today's advances in medical technology continue to hold
out the prospects for tomorrow's "medical miracle": new, and
likely more expensive, ways to treat disease and disability, to make
health care more accessible and effective, to extend and enhance
the quality of life. The challenge in the 1930s to find some way to
distribute and finance the miracles of "modern medicine" for all
Americans has its counterpart in the challenge to implement and
distribute the potential advances of the current decade - organ
transplants, artificial limbs, drug therapy for AIDS, Alzheimer's
disease, advances in neonatal and prenatal care, and the like. At
the same time, there is a new kind of technology to add to the
challenge in the 1980s - one that holds out the potential to evalu-
ate more precisely and more objectively both the quality of new
technological advances as well as that of the health care services
that are already widely available. Indeed, in many ways, the recent
advances in our ability to collect and assess data concerning the
effectiveness and efficiency of various health care services and
treatment practices could have as great an impact on health care
delivery in this country as any of the "medical miracles" with
which our medical technology has provided us. We stand just short
of the traditional border that has for so long insulated the individ-
ual physician's judgment from third-party and, in particular, non-
[Vol. 26:1
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medical assessment and review. Crossing that border holds out the
prospect for exactly the kind of reforms that so often have eluded
us: containing health care costs, not by risking a reduction in qual-
ity or accessibility, but by accurately targeting reform measures to
reduce unnecessary or marginally useful care, care that could be
provided more inexpensively in other settings, or patterns of medi-
cal practice that have no relation to actual outcome differences. In
addition, it holds out the potential for fundamental changes in the
manner in which health care institutions are governed and admin-
istered, not the least of which are substantial revisions in the role,
and the authority, of the individual physician. It would be difficult
to understate the potential for legal and political controversy that
could result.
Yet even as providers are facing more rigorous utilization and
quality assessment of their medical practice, they are also facing,
essentially for the first time, a more adversarial posture on the part
of employers, insurors, public third-party payers, and even some
consumers. Retroactive, actual-cost reimbursement has given way
to prospective, cost-averaging reimbursement schemes; friendly ne-
gotiations between payers and providers have become more akin to
arms-length bargaining. We no longer talk of fees and costs, but of
paying for health care on the basis of "price." Even the structure
of health care financing has been fundamentally altered by the at-
tempts to integrate the financing and delivery of services and a
variety of other efforts to foster competition among entities that
for so long eschewed even the use of the term. As the articles that
follow will illustrate, we are only beginning to sort out the legal
and political problems that these new developments will create.
Nevertheless, our technological capacity, the structure of
health care delivery and financing, and the specific problems that
they require us to address are constantly changing, the underlying
dilemma, the "pressing problem," remains what it always has been.
We are trying to provide an adequate level of care to all Americans
at an acceptable cost. It is intriguing to trace the potential for pro-
gress and the potential for controversy that will accompany new
developments in cost containment and quality assessment. Ulti-
mately, the impact of these developments must be measured
against the same axiomatic standard: we are trying to contain costs
and maintain the quality and accessibility of health care. Cost con-
tainment achieved by service reduction is certain to be rejected.
Quality measures may allow us to achieve economy through effi-
1989]
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ciency, but they will always be vulnerable to any perception that
they have done so by reducing the adequacy of what is available;
and, for that matter, they are just as likely to sharpen and increase
our appetite for what is adequate and acceptable. As previously
noted and reflected throughout the works to follow, developments
that lead to what we perceive as denied access will continue to be
politically unacceptable. Much has changed in the 1980s, but, to
our credit, our underlying value system seems to be remarkably
constant.
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